<i>Mycobacterium tuberculosis</i> –specific blood immune signatures distinguish sarcoidosis from tuberculosis disease

Sarcoidosis is a granulomatous systemic inflammatory disease predominantly affecting the lungs. It shares histopathological, clinical, and immune features with tuberculosis (TB). There are currently no diagnostic tests to formally identify sarcoidosis; instead, there is a need first to rule out the presence of other diseases, including TB. We hypothesized that Mycobacterium tuberculosis (Mtb)-specific immune signatures differ between sarcoidosis and TB. We characterized T-cell and monocyte signatures after Mtb antigen in vitro stimulation in the blood of patients with sarcoidosis compared to patients with TB disease and Mtb-sensitized and nonsensitized healthy controls using flow cytometry and transcriptomics on bulk PBMCs and sorted CD4 memory T cells. We found that sarcoidosis was associated with (1) a marked reduction in frequencies of antigen-reactive T cells in response to both Mtb peptides and Mtb lysate, (2) increased frequencies of monocytes, and (3) increased expression of monocyte-associated phagocytic genes compared to TB disease and Mtb-sensitized and nonsensitized healthy cohorts. A combination of Mtb peptide-specific T-cell and monocyte gene or flow cytometry signatures in Mtb peptide-stimulated PBMCs distinguished sarcoidosis from TB disease with high accuracy (area under the curve [AUC] = 0.91 and 0.96 for gene and flow cytometry signatures, respectively) and also distinguished sarcoidosis from Mtb-sensitized and nonsensitized healthy controls combined (AUC = 0.91 and 0.90 for gene and flow cytometry signatures, respectively). These findings highlight biological features that effectively distinguish sarcoidosis from TB and healthy populations and can be considered for the development of an optimized diagnostic method for sarcoidosis.

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-10-17
DOI
https://doi.org/10.1093/jimmun/vkaf274
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mycobacterium tuberculosis –specific blood immune signatures distinguish sarcoidosis from tuberculosis disease

Kendall Kearns, Simone A. Joosten, Monalisa Mondal, Marcel Veltkamp et al.
The Journal of Immunology
Sarcoidosis and Beryllium Toxicity Research
article

Mycobacterium tuberculosis –specific blood immune signatures distinguish sarcoidosis from tuberculosis disease

Kendall Kearns, Simone A. Joosten, Monalisa Mondal, Marcel Veltkamp, Bjoern Peters, Aruna Dharshan De Silva, Alessandra Aiello, Julie G. Burel, Wonder P. Drake, Leila Y. Chihab, Pandurangan Vijayanand, Desha Dilani, Thomas J. Scriba, Grégory Seumois, Delia Goletti, Cecilia S. Lindestam Arlehamn, Nabeela Khan, Krista E. van Meijgaarden, Angelique Kany Kany Luabeya, Michelle Fisher, Linda Petrone, Fabrizio Palmieri, Rashika N. Tennekoon, Hannah Hillman, Alice Wang, Catherine Cheng, Montse Janssen Bonás, Coline H.M. van Moorsel
article en

Abstract

Sarcoidosis is a granulomatous systemic inflammatory disease predominantly affecting the lungs. It shares histopathological, clinical, and immune features with tuberculosis (TB). There are currently no diagnostic tests to formally identify sarcoidosis; instead, there is a need first to rule out the presence of other diseases, including TB. We hypothesized that Mycobacterium tuberculosis (Mtb)-specific immune signatures differ between sarcoidosis and TB. We characterized T-cell and monocyte signatures after Mtb antigen in vitro stimulation in the blood of patients with sarcoidosis compared to patients with TB disease and Mtb-sensitized and nonsensitized healthy controls using flow cytometry and transcriptomics on bulk PBMCs and sorted CD4 memory T cells. We found that sarcoidosis was associated with (1) a marked reduction in frequencies of antigen-reactive T cells in response to both Mtb peptides and Mtb lysate, (2) increased frequencies of monocytes, and (3) increased expression of monocyte-associated phagocytic genes compared to TB disease and Mtb-sensitized and nonsensitized healthy cohorts. A combination of Mtb peptide-specific T-cell and monocyte gene or flow cytometry signatures in Mtb peptide-stimulated PBMCs distinguished sarcoidosis from TB disease with high accuracy (area under the curve [AUC] = 0.91 and 0.96 for gene and flow cytometry signatures, respectively) and also distinguished sarcoidosis from Mtb-sensitized and nonsensitized healthy controls combined (AUC = 0.91 and 0.90 for gene and flow cytometry signatures, respectively). These findings highlight biological features that effectively distinguish sarcoidosis from TB and healthy populations and can be considered for the development of an optimized diagnostic method for sarcoidosis.

The Journal of ImmunologyVol. 215(1)
Statens Serum Institut (DK), University of Maryland, Baltimore (US), La Jolla Institute for Immunology (US), University of Cape Town (ZA), General Sir John Kotelawala Defence University (LK), Leiden University Medical Center (NL), University Medical Center Utrecht (NL), University of California San Diego (US), Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT), St. Antonius Ziekenhuis (NL), Netherlands Heart Institute (NL), South African Tuberculosis Vaccine Initiative (ZA)
Openalex Percentile: Top 63%
Sarcoidosis and Beryllium Toxicity Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.